FDA Authorizes Early Access to Revolution's Pancreatic Cancer Pill

The US FDA has granted early access to Revolution Medicines' experimental pill, daraxonrasib, for metastatic pancreatic cancer patients. This treatment doubled survival in trials.

Read the full article and join the community discussion on Inimzu.